<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01205633</url>
  </required_header>
  <id_info>
    <org_study_id>CCSVI Registry</org_study_id>
    <nct_id>NCT01205633</nct_id>
  </id_info>
  <brief_title>Multi-center Registry for CCSVI Testing and Treatment</brief_title>
  <acronym>CCSVI</acronym>
  <official_title>Multi-center Registry for CCSVI Testing and Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hubbard Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hubbard Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients suspected of CCSVI (chronic cerebrospinal venous insufficiency) may be tested and if
      appropriate treated with catheter venoplasty by an interventional radiologist in their local
      community who has been credentialled either by the local hospital's IRB or a national IRB if
      the procedure is done in an outpatient facility. Catheter angioplasty is a long-established
      and accepted medical procedure, patients' insurance should but may not cover the testing or
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      more to follow
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    9/12/12 FDA stopped enrollment pending device exemption(IDE)application.
  </why_stopped>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Short-Form 36 (SF36) Quality of Life Instrument</measure>
    <time_frame>Baseline and at 1, 6 and 12 months after treatment</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>CCSVI</condition>
  <condition>Chronic Cerebrospinal Venous Insufficiency</condition>
  <condition>Venous Malformations of CNS Draining Veins</condition>
  <arm_group>
    <arm_group_label>CNS draining vein abnormalities</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venous angioplasty</intervention_name>
    <description>catheter venous angioplasty via femoral vein approach</description>
    <arm_group_label>CNS draining vein abnormalities</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suspected of obstructions in the veins draining the central nervous system which
        may adversely affect CNS function
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Referral by patients primary treating physician for suspected CCSVI

        Exclusion Criteria:

        Abnormal kidney function Allergy to either or both of the imaging contrast agents Pacemaker
        or other implantable device Ferrous metal in or on the body Claustrophobia Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David R Hubbard, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Hubbard Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vascular Access Center of Downey</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North County Radiology</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Access Care of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia endovascular Associates</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Endovascular Associates</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dayton Interventional Radiology</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Valley Interventional Associates</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Vascular Clinic</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Access Center of Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>14220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hubbardfoundation.org</url>
  </link>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2010</study_first_submitted>
  <study_first_submitted_qc>September 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2010</study_first_posted>
  <last_update_submitted>September 15, 2012</last_update_submitted>
  <last_update_submitted_qc>September 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neurodegenerative disease</keyword>
  <keyword>neurovascular disease</keyword>
  <keyword>fatigue</keyword>
  <keyword>Hubbard Foundation</keyword>
  <keyword>angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

